INTERCEPT PHARMACEUTICALS, INC.·4

Mar 2, 7:00 PM ET

Weyer Christian 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Mar 2, 2021

Insider Transaction Report

Form 4
Period: 2021-02-27
Weyer Christian
EVP Research and Development
Transactions
  • Tax Payment

    Common Stock

    2021-02-27$21.66/sh357$7,73327,387 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person.

Documents

1 file
  • 4
    tm218450d1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT